HCW Biologics Inc.
HCWB
$4.13
-$0.115-2.71%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.63% | -20.12% | -89.19% | -105.09% | -52.90% |
| Total Depreciation and Amortization | 25.92% | 4.33% | -30.79% | -8.24% | 23.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -80.45% | -83.16% | 793.41% | 613.18% | 502.57% |
| Change in Net Operating Assets | 457.92% | 392.98% | 434.59% | 678.99% | -162.62% |
| Cash from Operations | 37.11% | 36.81% | 31.78% | 6.19% | -80.82% |
| Capital Expenditure | 97.81% | 95.78% | -51.19% | 63.15% | 42.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -41.12% | -41.12% |
| Cash from Investing | -103.32% | -106.89% | -151.90% | 13.40% | -38.30% |
| Total Debt Issued | 194.57% | -- | -- | -42.62% | -72.86% |
| Total Debt Repaid | -79.71% | -211.75% | -1,207.78% | -- | -- |
| Issuance of Common Stock | 174.17% | 39,651.05% | 16,134.19% | 14,615.79% | 16,290.26% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 168.49% | 106,733.56% | 22,935.29% | -2.48% | -32.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 79.19% | 105.76% | 31.86% | 21.12% | -5,347.80% |